We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01336842
Recruitment Status : Completed
First Posted : April 18, 2011
Last Update Posted : January 9, 2018
Novartis Pharmaceuticals
Information provided by (Responsible Party):
University of California, Davis

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : January 2017
  Study Completion Date : June 2017